Cargando…
Micheliolide prevents estrogen deficiency-induced bone loss via inhibiting osteoclast bone resorption
Osteoporosis is one of the major health problems characterized by decreased bone density and increased risk of fractures. Nowadays, the treating strategies against osteoporosis are efficient, but still have some drawbacks. Micheliolide, a guaianolide sesquiterpene lactone isolated from Michelia comp...
Autores principales: | Gan, Ziyang, Huang, Junming, Xu, Mingyou, Yuan, Xingshi, Shang, Xifu, Chen, Xi, Chen, Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599737/ https://www.ncbi.nlm.nih.gov/pubmed/37827691 http://dx.doi.org/10.18632/aging.205111 |
Ejemplares similares
-
Cepharanthine Prevents Estrogen Deficiency-Induced Bone Loss by Inhibiting Bone Resorption
por: Zhou, Chen-he, et al.
Publicado: (2018) -
Boldine Ameliorates Estrogen Deficiency-Induced Bone Loss via Inhibiting Bone Resorption
por: Chen, Kun, et al.
Publicado: (2018) -
Estrogen Inhibits Bone Resorption by Directly Inducing Apoptosis of the Bone-resorbing Osteoclasts
por: Kameda, Takashi, et al.
Publicado: (1997) -
CircFam190a: a critical positive regulator of osteoclast differentiation via enhancement of the AKT1/HSP90β complex
por: Chen, Kun, et al.
Publicado: (2023) -
TRPV6 is a potential regulator of bone resorption in bone loss induced by estrogen deficiency
por: Ma, Jun, et al.
Publicado: (2021)